Ken Griffin West Pharmaceutical Services Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$277.16 - $333.3 $332,592 - $399,960	1,200 Added 2.55%	48,200 $14.5 Million
Q2 2024 Aug 14, 2024	BUY	$314.68 - $395.94 $4.5 Million - $5.66 Million	14,300 Added 43.73%	47,000 $15.5 Million
Q1 2024 May 15, 2024	BUY	$338.27 - $413.0 $4.03 Million - $4.91 Million	11,900 Added 57.21%	32,700 $12.9 Million
Q4 2023 Feb 14, 2024	SELL	$318.29 - $392.21 $732,067 - $902,083	-2,300 Reduced 9.96%	20,800 $7.32 Million
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $4.01 Million - $4.66 Million	11,300 Added 95.76%	23,100 $8.67 Million
Q2 2023 Aug 14, 2023	BUY	$334.63 - $382.47 $836,575 - $956,175	2,500 Added 26.88%	11,800 $4.51 Million
Q1 2023 May 15, 2023	SELL	$232.5 - $346.47 $2.12 Million - $3.15 Million	-9,100 Reduced 49.46%	9,300 $3.22 Million
Q4 2022 Feb 14, 2023	BUY	$209.34 - $261.61 $795,492 - $994,118	3,800 Added 26.03%	18,400 $4.33 Million
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $541,376 - $756,030	2,200 Added 17.74%	14,600 $3.59 Million

801

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.8B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.